Gilead Sciences, Inc.
CH ˙ SWX ˙ US3755581036
SecurityCH:GILD / Gilead Sciences, Inc.
InstitutionGlobal Retirement Partners, LLC
Latest Disclosed Ownership32,281 shares
Latest Disclosed Value $ 3,962,226
Global Retirement Partners, LLC reports 80.67% increase in ownership of GILD / Gilead Sciences, Inc.

On February 6, 2026 - Global Retirement Partners, LLC filed a 13F-HR form disclosing ownership of 32,281 shares of Gilead Sciences, Inc. (CH:GILD) valued at $3,962,226 USD as of December 31, 2025. The entity filed a previous 13F-HR on October 21, 2025 disclosing 17,867 shares of Gilead Sciences, Inc.. This represents a change in shares of 80.67% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-02-06 2025-12-31 13F GILEAD SCIENCES COM 375558103 32,281 14,414 80.67 3,962 99.80 0.0703
2025-10-21 2025-09-30 13F GILEAD SCIENCES COM 375558103 17,867 -2,207 -10.99 1,983 -10.88 0.0444
2025-08-12 2025-06-30 13F GILEAD SCIENCES COM 375558103 20,074 11,092 123.49 2,226 168.40 0.0552
2025-01-31 2024-12-31 13F GILEAD SCIENCES COM 375558103 8,982 194 2.21 830 12.64 0.0238
2024-10-16 2024-09-30 13F GILEAD SCIENCES COM 375558103 8,788 933 11.88 737 36.80 0.0223
2024-07-23 2024-06-30 13F GILEAD SCIENCES COM 375558103 7,855 1,921 32.37 539 23.96 0.0169
2024-04-23 2024-03-31 13F GILEAD SCIENCES COM 375558103 5,934 -810 -12.01 435 -25.04 0.0162
2024-01-18 2023-12-31 13F GILEAD SCIENCES COM 375558103 6,744 1,991 41.89 580 63.10 0.0243
2023-10-13 2023-09-30 13F GILEAD SCIENCES COM 375558103 4,753 445 10.33 355 6.93 0.0179
2023-07-20 2023-06-30 13F GILEAD SCIENCES COM 375558103 4,308 -100 -2.27 332 -5.14 0.0162
2023-05-08 2023-03-31 13F GILEAD SCIENCES COM 375558103 4,408 1,663 60.58 350 48.94 0.0186
2023-02-13 2022-12-31 13F GILEAD SCIENCES COM 375558103 2,745 308 12.64 236 23.04 0.0162
2022-11-03 2022-09-30 13F GILEAD SCIENCES COM 375558103 2,437 168 7.40 191 36.43 0.0145
2022-07-15 2022-06-30 13F GILEAD SCIENCES COM 375558103 2,269 104 4.80 140 0.72 0.0112
2022-07-14 2022-03-31 13F GILEAD SCIENCES COM 375558103 2,165 2,165 139 0.0109
2022-01-21 2021-12-31 13F GILEAD SCIENCES COM 375558103 0 -2,018 -100.00 0 -100.00
2021-10-22 2021-09-30 13F GILEAD SCIENCES COM 375558103 2,018 553 37.75 141 39.60 0.0139
2021-07-15 2021-06-30 13F GILEAD SCIENCES COM 375558103 1,465 250 20.58 101 27.85 0.0103
2021-04-14 2021-03-31 13F GILEAD SCIENCES COM 375558103 1,215 -223 -15.51 79 -5.95 0.0092
2021-01-13 2020-12-31 13F GILEAD SCIENCES COM 375558103 1,438 105 7.88 84 0.00 0.0105
2020-10-09 2020-09-30 13F GILEAD SCIENCES COM 375558103 1,333 -294 -18.07 84 -32.80 0.0123
2020-07-13 2020-06-30 13F GILEAD SCIENCES COM 375558103 1,627 -477 -22.67 125 -20.38 0.0199
2020-04-28 2020-03-31 13F GILEAD SCIENCES COM 375558103 2,104 -251 -10.66 157 2.61 0.0297
2020-01-23 2019-12-31 13F GILEAD SCIENCES COM 375558103 2,355 -167 -6.62 153 -4.37 0.0234
2019-11-19 2019-09-30 13F GILEAD SCIENCES COM 375558103 2,522 351 16.17 160 8.84 0.0263
2019-11-19 2019-06-30 13F GILEAD SCIENCES COM 375558103 2,171 295 15.72 147 20.49 0.0281
2019-05-07 2019-03-31 13F GILEAD SCIENCES COM 375558103 1,876 1 0.05 122 4.27 0.0295
2019-02-22 2018-12-31 13F GILEAD SCIENCES COM 375558103 1,875 -307 -14.07 117 -30.36 0.0299
2018-10-17 2018-09-30 13F GILEAD SCIENCES COM 375558103 2,182 202 10.20 168 20.00 0.0380
2018-08-13 2018-06-30 13F GILEAD SCIENCES COM 375558103 1,980 -114 -5.44 140 -11.39 0.0354
2018-08-10 2018-03-31 13F GILEAD SCIENCES COM 375558103 2,094 -27 -1.27 158 3.95 0.0435
2018-08-13 2017-12-31 13F GILEAD SCIENCES COM 375558103 2,121 472 28.62 152 13.43 0.0418
2018-08-10 2017-09-30 13F GILEAD SCIENCES COM 375558103 1,649 247 17.62 134 35.35 0.0554
2018-08-10 2017-06-30 13F GILEAD SCIENCES COM 375558103 1,402 252 21.91 99 26.92 0.0466
2018-08-10 2017-03-31 13F GILEAD SCIENCES COM 375558103 1,150 -150 -11.54 78 -16.13 0.0436
2018-08-10 2016-12-31 13F GILEAD SCIENCES COM 375558103 1,300 1,300 93 0.0625
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.